Birch Grove Capital

Latest statistics and disclosures from Birch Grove Capital's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Birch Grove Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Birch Grove Capital

Birch Grove Capital holds 6 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Mitek Sys Note 0.750% 2/0 (Principal) 66.6 $8.7B -42% 9.4M 930.88
 View chart
Karyopharm Therapeutics Note 3.000% 10/1 (Principal) 24.5 $3.2B -25% 6.0M 535.15
 View chart
The Realreal Note 1.000% 3/0 (Principal) 8.6 $1.1B -48% 3.2M 350.00
 View chart
Churchill Capital Corp Vii *w Exp 02/29/202 (CVIIW) 0.2 $25M 80k 306.10
 View chart
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) 0.1 $9.2M +42% 1.2M 7.68
 View chart
Multiplan Corporation *w Exp 02/13/202 (MPLNW) 0.1 $7.5M 75k 100.00
 View chart

Past Filings by Birch Grove Capital

SEC 13F filings are viewable for Birch Grove Capital going back to 2015

View all past filings